EPISODE · May 14, 2025 · 5 MIN
B+L Receives Approval in Europe for LuxLife IOL
from Eyewire News: The Podcast · host Eyewire News
Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
B+L Receives Approval in Europe for LuxLife IOL
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m